Heartland Advisors Inc. Has $10.21 Million Stock Position in Envista Holdings Corporation $NVST

Heartland Advisors Inc. lessened its holdings in Envista Holdings Corporation (NYSE:NVST) by 6.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 402,353 shares of the company’s stock after selling 26,644 shares during the quarter. Heartland Advisors Inc. owned approximately 0.25% of Envista worth $10,208,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. California Public Employees Retirement System boosted its holdings in shares of Envista by 3.9% in the first quarter. California Public Employees Retirement System now owns 329,627 shares of the company’s stock valued at $8,363,000 after buying an additional 12,373 shares during the period. Kera Capital Partners Inc. raised its holdings in shares of Envista by 9.6% during the first quarter. Kera Capital Partners Inc. now owns 18,316 shares of the company’s stock worth $465,000 after acquiring an additional 1,609 shares during the period. Assetmark Inc. lifted its position in Envista by 11.3% in the 1st quarter. Assetmark Inc. now owns 51,495 shares of the company’s stock valued at $1,306,000 after acquiring an additional 5,222 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in Envista in the 1st quarter valued at $212,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in Envista by 82.3% in the 1st quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,069 shares of the company’s stock worth $433,000 after purchasing an additional 7,708 shares during the period.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Citigroup initiated coverage on shares of Envista in a report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price for the company. JPMorgan Chase & Co. boosted their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Robert W. Baird increased their price objective on shares of Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Evercore restated an “outperform” rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. Finally, Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $28.54.

Envista Stock Performance

NYSE NVST opened at $26.73 on Friday. The firm has a 50-day moving average price of $24.93 and a two-hundred day moving average price of $25.58. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42. The company has a market capitalization of $4.35 billion, a P/E ratio of 65.18, a P/E/G ratio of 1.52 and a beta of 0.86. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.03 million. During the same quarter last year, the business earned $0.24 earnings per share. Envista’s revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts anticipate that Envista Holdings Corporation will post 1.42 earnings per share for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.